Prelude Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74065P1012
USD
1.54
0.2 (14.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
131.46
237.09
195.44
285.90
212.18
17.03
Shareholder's Funds
131.46
237.09
195.44
285.90
212.18
17.03
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
2.70
1.48
1.83
1.74
0.00
0.26
Secured Loans
2.70
1.48
1.83
1.74
0.00
0.26
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
18.41
18.75
3.36
0
0.03
0.01
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
18.41
18.75
3.36
0.00
0.03
0.00
Current Liabilities
Trade Payables
0.00
0.00
0.00
0.00
0.00
1.97
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
25.64
21.83
21.70
19.20
11.38
4.83
Total Liabilities
175.51
277.67
220.50
305.10
223.59
21.87
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
40.72
41.30
10.02
7.63
3.56
2.20
Less: Accumulated Depreciation
5.26
3.57
3.32
2.00
1.08
0.56
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
35.47
37.74
6.70
5.64
2.48
1.65
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
4.04
4.04
4.04
4.04
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.11
0.29
5.38
0.30
0.00
0.00
Total Non-Current Assets
39.62
42.08
16.12
9.98
2.78
1.65
Current Assets Loans & Advances
Current Investments
121.14
207.64
171.12
259.40
0.00
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
0.00
0.00
0.00
Cash and Bank
12.47
25.29
30.61
31.83
218.31
18.88
Other Current Assets
133.61
232.94
201.73
291.23
218.31
18.88
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
135.90
235.59
204.38
295.12
220.81
20.22
Net Current Assets (Including Current Investments)
110.25
213.76
182.68
275.91
209.43
15.39
Total Current Assets Excluding Current Investments
135.90
235.59
204.38
295.12
220.81
20.22
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
175.51
277.67
220.50
305.10
223.59
21.87
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
2.70
1.48
1.83
1.74
0.00
0.26
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -1.81% vs 458.04% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -6.01% vs 463.28% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is -42.32% vs 15.27% in Dec 2023

Compare Balance Sheet Results of Prelude Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
131.46
182.27
-50.81
-27.88%
Shareholder's Funds
131.46
182.27
-50.81
-27.88%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
2.70
10.25
-7.55
-73.66%
Secured Loans
2.70
10.25
-7.55
-73.66%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
18.41
1.72
16.69
970.35%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
18.41
1.72
16.69
970.35%
Current Liabilities
Trade Payables
0
2.22
-2.22
-100.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
25.64
15.11
10.53
69.69%
Total Liabilities
175.51
199.09
-23.58
-11.84%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
40.72
44.51
-3.79
-8.51%
Less: Accumulated Depreciation
5.26
19.98
-14.72
-73.67%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
35.47
24.53
10.94
44.60%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
4.04
0
4.04
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.11
0
0.11
0.00%
Total Non-Current Assets
39.62
24.53
15.09
61.52%
Current Assets Loans & Advances
Current Investments
121.14
0
121.14
0.00%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
12.47
172.68
-160.21
-92.78%
Other Current Assets
133.61
173.53
-39.92
-23.00%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
135.90
174.57
-38.67
-22.15%
Net Current Assets (Including Current Investments)
110.25
159.46
-49.21
-30.86%
Total Current Assets Excluding Current Investments
135.90
174.57
-38.67
-22.15%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
175.51
199.09
-23.58
-11.84%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
2.70
10.25
-7.55
-73.66%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
No Borrowings in the last few periods
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 18.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.81% vs 458.04% in Dec 2023

Annual - Fixed Assets
Fixed Assets 35.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -6.01% vs 463.28% in Dec 2023

Annual - Investments
Investments 4.04 Million
in Dec 2024

Figures in Million
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 135.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -42.32% vs 15.27% in Dec 2023